GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $240,000 | +18.8% | 3,031 | -26.8% | 0.00% | +100.0% |
| Q3 2019 | $202,000 | -22.6% | 4,140 | -16.7% | 0.00% | -50.0% |
| Q2 2019 | $261,000 | +6425.0% | 4,968 | +6110.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 80 | -2.4% | 0.00% | – |
| Q4 2018 | $3,000 | -82.4% | 82 | -81.0% | 0.00% | – |
| Q3 2018 | $17,000 | +21.4% | 432 | +54.3% | 0.00% | – |
| Q2 2018 | $14,000 | 0.0% | 280 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | -94.1% | 280 | -95.4% | 0.00% | -100.0% |
| Q4 2017 | $239,000 | +7866.7% | 6,080 | +5980.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |